Thank you for bringing our attention to that, Acclivity.
And all these years later we are all on tenterhooks about whether sales will happen. And in the meantime at least one somewhat hopeful study for heart failure (I found it on line. However, it is only Phase 2, so more money would be needed to do a larger study.) Also a breakthrough designation status achieved for renal failure, and an obvious plan to partner in a study there not followed up.
A ten year history of flitting around projects.
I accept that some holders feel we were better off with the former management, but PB has a great track record in what is most needed now, driving sales. Also,according to LinkedIn, RV's wife is back fighting for her life, which might have made it hard for him to give the absolute attention to Impedimed at this make or break time.(That sounds a bit harsh, but may be true )GLTAH
Thank you for bringing our attention to that, Acclivity.And all...
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
0.002(2.50%) |
Mkt cap ! $161.8M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.3¢ | 8.1¢ | $6.826K | 83.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24782 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 30499 | 3 |
View Market Depth
| Last trade - 10.27am 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.1¢ |
Change
0.002 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.2¢ | 8.1¢ | 22377 | ||
| Last updated 10.16am 15/05/2024 ? | |||||
| IPD (ASX) Chart |